Literature DB >> 12970897

Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B.

Ke-Xia Wang1, Jiang-Long Peng, Xue-Feng Wang, Ye Tian, Jian Wang, Chao-Pin Li.   

Abstract

AIM: To study the levels of T lymphocyte subsets and membrane interleukin-2 receptor (mIL-2R) on surface of peripheral blood mononuclear cells (PBMCs) of patients with hepatitis B and its role in the pathogenesis of hepatitis B.
METHODS: The levels of T lymphocyte subsets and mIL-2R in PBMC before and after being stimulated with PHA were detected by biotin-streptavidin (BSA) technique in 196 cases of hepatitis B.
RESULTS: In patients with hepatitis B, the levels of CD(3)(+), CD(4)(+) cells, and the ratio of CD(4)(+) cells/CD(8)(+) cells were lower, but the level of CD(8)(+) cells was higher than those in normal controls (42.20+/-6.01 vs 65.96+/-6.54, 38.17+/-5.93 vs 41.73+/-6.40, 0.91+/-0.28 vs 1.44+/-0.31, 39.86+/-6.36 vs 30.02+/-4.54, P<0.01). The total expression level of mIL-2R in PBMC before and after being stimulated with PHA was also lower than those in normal controls (3.47+/-1.55 vs 4.52+/-1.49, 34.03+/-2.94 vs 37.95+/-3.00, P<0.01). In all the patients with hepatitis B, the levels of T lymphocyte subsets and mIL-2R in PBMC with HBV-DNA (+) were lower than those with HBV-DNA (-), which were significantly different (39.57+/-7.11 vs 44.36+/-5.43, 34.36+/-7.16 vs 40.75+/-5.87, 37.82+/-6.54 vs 41.72+/-6.21, 0.88+/-0.33 vs 0.99+/-0.27, 2.82+/-1.62 vs 3.85+/-1.47, 31.56+/-3.00 vs 35.84+/-2.83, P<0.01). In addition, the levels of CD(3)(+), CD(4)(+), CD(8)(+) cells, the ratio of CD(4)(+) cells /CD(8)(+) cells and mIL-2R among different courses of hepatitis B were all significantly different (F=3 723.18, P<0.01. F=130.43, P<0.01. F=54.01, P<0.01. F=2.99, P<0.05. F=7.16, P<0.01).
CONCLUSION: Both cellular and humoral immune functions are obviously in disorder in patients with hepatitis B, which might be closely associated with the chronicity in patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970897      PMCID: PMC4656665          DOI: 10.3748/wjg.v9.i9.2017

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  A new hypothesis of pathogenetic mechanism of viral hepatitis B and C.

Authors:  D X Liu
Journal:  Med Hypotheses       Date:  2001-03       Impact factor: 1.538

2.  Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.

Authors:  F Izzo; F Cremona; F Ruffolo; R Palaia; V Parisi; S A Curley
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

3.  Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells.

Authors:  S M Akbar; M Abe; T Masumoto; N Horiike; M Onji
Journal:  J Hepatol       Date:  1999-05       Impact factor: 25.083

4.  Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection.

Authors:  F S Wang; L H Xing; M X Liu; C L Zhu; H G Liu; H F Wang; Z Y Lei
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

5.  Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.

Authors:  S K Sarin; V Thakur; R C Guptan; S Saigal; V Malhotra; S P Thyagarajan; B C Das
Journal:  J Gastroenterol Hepatol       Date:  2001-06       Impact factor: 4.029

6.  Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.

Authors:  B D Livingston; J Alexander; C Crimi; C Oseroff; E Celis; K Daly; L G Guidotti; F V Chisari; J Fikes; R W Chesnut; A Sette
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

7.  Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice.

Authors:  M Chen; M Sällberg; S N Thung; J Hughes; J Jones; D R Milich
Journal:  Antiviral Res       Date:  2001-11       Impact factor: 5.970

8.  Hepatitis B virus-induced liver injury and altered expression of carcinogen metabolising enzymes: the role of the HBx protein.

Authors:  P Chomarat; J M Rice; B L Slagle; C P Wild
Journal:  Toxicol Lett       Date:  1998-12-28       Impact factor: 4.372

Review 9.  Global control of hepatitis B virus infection.

Authors:  Jia-Horng Kao; Ding-Shinn Chen
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

Review 10.  [Chronic hepatitis B. Recent advances in diagnosis and treatment].

Authors:  Mauro Bernardi; Maurizio Biselli; Annagiulia Gramenzi
Journal:  Recenti Prog Med       Date:  2002 Jul-Aug
View more
  9 in total

1.  Effect of liniment levamisole on cellular immune functions of patients with chronic hepatitis B.

Authors:  Ke-Xia Wang; Li-Hua Zhang; Jiang-Long Peng; Yong Liang; Xue-Feng Wang; Hui Zhi; Xiang-Xia Wang; Huan-Xiong Geng
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population.

Authors:  Ping-An Zhang; Jian-Min Wu; Yan Li; Xiang-Sheng Yang
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

3.  Expression of T subsets and mIL-2R in peripheral blood of newborns with hypoxic ischemic encephalopathy.

Authors:  Jian Wang; Qin Lu
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

4.  Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.

Authors:  Jing You; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Lin Zhuang; Hong-Ying Chen; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

5.  Effect of Hejie decoction on T cell immune state of chronic hepatitis B patients.

Authors:  Shi-Jun Zhang; Ze-Xiong Chen; Shao-Xian Lao; Bi-Jun Huang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

6.  Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function tests.

Authors:  Jing You; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Lin Zhuang; Hong-Ying Chen; Jun-Hua Huang; Bao-Zhang Tang
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

7.  HBV cccDNA in patients' sera as an indicator for HBV reactivation and an early signal of liver damage.

Authors:  Ying Chen; Johnny Sze; Ming-Liang He
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

8.  Expression of CD11b and CD18 on polymorphonuclear neutrophils stimulated with interleukin-2.

Authors:  Bahaa K A Abdel-Salam; Hossam Ebaid
Journal:  Cent Eur J Immunol       Date:  2014-06-27       Impact factor: 2.085

9.  Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection.

Authors:  Rm Mukherjee; P Balkumar Reddy; Jyothi Arava; Pn Rao; Sasikala Mitnala; R Gupta; Dn Reddy
Journal:  Hepat Med       Date:  2010-11-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.